Multiple Infusions of Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (EMD 55 900) in Patients with Recurrent Malignant Gliomas

Author： Stragliotto G. Vega F. Stasiecki P. Gropp P. Poisson M. Delattre J.-Y.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.32, Iss.4, 1996-04, pp. : 636-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1610-1618

Spandidos Publications

Access to resources Recommend Favorite

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

By Arnoletti J. Frolov A. Eloubeidi M. Keene K. Posey J. Wood T. Greeno Edward Jhala N. Varadarajulu S. Russo S. Christein J. Oster R. Buchsbaum D. Vickers S.

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite

Role of an Anti-epidermal Growth Factor Receptor in Treating Cancer

By Waksal H.W.

Cancer and Metastasis Reviews, Vol. 18, Iss. 4, 1999-12 ,pp. : 427-436

Springer Publishing Company

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies for Advanced Breast Cancer

By Campos Susana

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 757-768

Informa Healthcare

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor Strategies to Enhance Radiation Action

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 5, 2003-09 ,pp. : 327-333

Bentham Science Publishers

Access to resources Recommend Favorite